Iranian Society of Pathology- Scientific News
Medscape Clinical Trend: Metformin⁠

Clear images and colors  | Post date: 2020/09/1 | 
Medscape Clinical Trend: Metformin⁠⠀
⁠⠀
The most commonly prescribed drug for #type2 #diabetes may be associated with reduced risk for death due to COVID-19. ⁠⠀
⁠⠀
The latest results, which are not yet peer reviewed, were recently published online and show a significant reduction in mortality in patients with diabetes and COVID-19 who used #metformin. ⁠⠀
⁠⠀
These findings support the results of four previous studies that also showed a reduction in mortality among metformin users compared with nonusers. ⁠⠀
⁠⠀
However, experts say that the randomized controlled trials needed to conclusively prove this benefit are "almost impossible in the context of COVID-19."⁠⠀
⁠⠀
Metformin has been in the news this week for other reasons as well. Tap the link in our bio to read further study analysis.⁠

Topic URL in Iranian Society of Pathology website:
http://iranpath.org/find.php?item=1.19.444.en
Back to content primary page